RESEARCH
Open Access
Abstract
Background: Nutrients such as -3 fatty acids including fish oil components eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA) suppress the growth and promote apoptosis of tumor cells, improve immune function
and reduce the effects of systemic inflammatory response syndrome. We sought to investigate the effect of -3 fish oil
fat emulsion-based parenteral nutrition (PN) on nutritional state, immune function, inflammatory reaction, expression of
tumor factors and complication incidence in patients after surgical resection of gastric cancer.
Methods: Forty-eight patients after surgical operation of gastric tumor in hospital were randomly divided into the
control group and intervention group. Patients in both groups were treated with iso-nitrogen and iso-caloric parenteral
nutrition support. In addition, the intervention group received -3 fish oil fat emulsion and the control group received
soybean oil. The indicators of nutrition, immune function and inflammation in the two groups were detected on the
day before the operation and postoperative day 6. The rate of complication was compared between the two groups.
Results: There was no significant difference in nutritional state, liver function and renal function between the two
groups (P > 0.05). However, the levels of inflammatory markers were significantly decreased (P < 0.01), and the rate of
complication was also decreased in the intervention group as compared with the control group.
Conclusions: -3 fish oil fat emulsion-based parenteral nutrition alleviates the inflammatory reaction and reduces the
rate of inflammatory complications.
Keywords: -3 fish oil, Immune nutrition, Eicosapentaenoic acid (EPA), Docosahexaenoic acid (DHA), Gastric tumor,
Parenteral nutrition
Background
Omega-3 polyunsaturated fatty acids including fish oil
components eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are essential for humans as they
cannot be synthesized by the human body. There have
been an increasing number of studies on immune nutrition and cancer therapy over the recent years, and preliminary data suggest that EPA and DHA suppress the
growth and promote apoptosis of tumor cells, as well as
improve immune function and reduce the effects of
* Correspondence: caiqingpingwcwk@163.com
Equal contributors
Department of General Surgery, Shanghai Changzheng Hospital, Second
Military Medical University, Shanghai, China
systemic inflammatory response syndrome [1-5]. A recent survey revealed that the content of polyunsaturated fatty acids is likely inadequate in the regular diet of
Chinese [6]. A randomized controlled study evaluated
the effect of omega-3 fatty acid-supplemented total parenteral nutrition (TPN) on the clinical outcomes of patients
with hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC) showed that postoperative administration
of omega-3 fatty acid reduced infection and improved
postoperative hepatic function recovery [7]. Short-term
pre-operative infusion of fish oil alone has been shown to
improve the postoperative immune response of gastrointestinal cancer patients but exhibited no apparent effect
on postoperative infections or length of intensive care unit
2014 Wei et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
(ICU) and hospital stay [8]. A recent meta analysis evaluated n-3 PUFA-enriched parenteral nutrition (PN) regimens in elective surgical and ICU patients and showed
that these regimens are safe and effective in reducing the
infection rate and hospital/ICU stay in surgical and ICU
patients [9].
The above findings prompted us to speculate that f -3
fish oil fat emulsion-supplemented PN could be beneficial
to the overall functional recovery of gastric tumor patients.
Here, we designed a prospective, randomized, singleblinded control clinical trial to investigate the effect of -3
fish oil fat emulsion-supplemented PN on nutritional state,
immune function, inflammatory reaction, expression of
tumor factors and complication incidence in patients after
surgery of gastric tumors.
Methods
Patient selection
Page 2 of 6
Nutrition
Variables
Number
20
26
15:11
>0.05
Age (years)*
59(3674)
50.5(2975)
>0.05
Height (cm)
166.5(150185)
168(155183)
>0.05
Weight (kg)
65(4589)
62(4288)
>0.05
22.2(15.728.1)
>0.05
>0.05
Body mass
22.5(17.829.7)
index (kg/m2)*
TNM stage
I
11
13
II
13
Page 3 of 6
Table 2 Comparison of pre- and postoperative nutritional indices of the study patients
Indices
Preoperative
Postoperative
Study group
Control group
Study group
Control group
TP
68.97 6.38
68.35 7.66
0.77
64.58 6.14*
64.88 6.47
0.87
ALB
41.52 3.89
39.26 4.52
0.08
37.17 6.16*
36.07 4.63*
0.49
PA
242.96 66.25
218.03 50.36
0.15
191.42 55.31*
197.63 41.65
0.67
RBP
0.034 0.012
0.028 0.010
0.07
0.049 0.058
0.032 0.011
0.15
TF
2.577 0.63
2.447 0.48
0.44
1.934 0.45*
1.93 0.42*
0.97
3.85 1.64
0.17
TC
3.84 0.61
4.22 1.06
0.16
3.29 0.72
TP, total protein; ALB, albumin; PA, pre-albumin; RBP, retinol binding protein; TF, transferrin; TC, total cholesterol.
*Indicates significant difference vs. the preoperative value in the same group.
Results
Patient demographic and baseline characteristics
Fifty-two patients with gastric tumor were enrolled including 26 males and 26 females aged between 29 and
Table 3 Comparison of the pre- and postoperative immune indices of the study patients
Indices
Preoperative
Postoperative
TLC
1.31 0.42
1.28 0.41
0.701
1.12 0.37
1.08 0.36
0.438
CD3
67.14 8.58
65.74 9.20
0.599
64.71 10.51
66.07 7.64
0.615
CD4
42.48 8.91
38.92 9.80
0.211
44.23 9.46
41.74 8.67
0.358
CD8
22.69 8.85
23.92 7.57
0.61
19.85 7.36
21.47 5.94
0.414
CD4/CD8
2.34 1.19
1.90 1.06
0.212
2.61 1.33
2.16 1.00
0.198
Page 4 of 6
Table 4 Comparison of the pre- and postoperative inflammatory indices of the study patients
Indices
Preoperative
Postoperative
Study group
Control group
Study group
Control group
WBC
5.26 3.09
4.76 1.37
0.331
7.42 2.79
5.95 1.46*
0.025*
CRP
3.98 2.17
5.64 9.83
0.269
30.90 31.17*
33.62 7.36*
0.733
IL-1
201.51 16.06
196.38 21.90
0.422
302.32 37.61*
332.61 35.34*
0.011*
IL-6
15.53 61.57
16.56 62.04
0.950
14.35 45.95
48.25 67.49*
0.007*
TNF-
15.31 52.61
19.77 52.38
0.889
12.05 60.31
53.56 75.23*
0.005*
data, these parameters were not statistically different in either the control or intervention group.
Inflammatory response
Discussion
Cancer is a wasting disease and cancer patients are at a
high risk of malnutrition. Due to the possibility that parenteral nutrition may stimulate tumor growth and proliferation, parenteral nutritional support for tumor patients is
controversial [10]. However, it is clear that nutritional support is important for patients undergoing surgery or receiving chemotherapy, radiation therapy and other cancer
treatments, which also helps maintain the bodys immunity. Appropriate perioperative nutritional support is
important in improving the nutritional status of the
body, maintaining the structure and function of the organs, reducing the incidence of surgical mortality and
postoperative complications, and improving the patients quality of life [11]. It also provides a good platform for the body to withstand the next round of
treatment [11]. Our clinical trial suggests that a standard calorie parenteral nutrition program such as the
one used in the current trial can effectively maintain the
nutritional status of patients post surgery.
-3 fish oil is made up of the fatty acids EPA and
DHA, which the body itself can only synthesize a very
small amount. EPA and DHA can increase the amount
of phospholipid omega-3 in cell membranes, while reducing inflammatory eicosane generation by increasing
the amount of non-inflammatory eicosane competing in
the arachidonic acid synthetic pathway. The release of
antibodies and the phagocytic activity of macrophages are
Table 5 Comparison of the preoperative and postoperative tumor factors of the study patients
Indices
Preoperative
Postoperative
VEGF
346.21 366.55
271.08 276.68
0.389
200.35 183.61
177.30 167.83
0.622
IGF-1
403.31 28.50
393.81 34.53
0.316
369.13 53.23
341.87 75.27
0.119
Page 5 of 6
3/20
1/26
P = 0.303
Abdominal infection
1/20
0/26
P = 0.435
Urinary infection
1/20
0/26
P = 0.435
Pulmonary infection
1/20
0/26
P = 0.435
Total complications
6/20
1/26
P = 0.033
Page 6 of 6
References
1. Fukui M, Kang KS, Okada K, Zhu BT: EPA, an omega-3 fatty acid, induces
apoptosis in human pancreatic cancer cells: role of ROS accumulation,
caspase-8 activation, and autophagy induction. J Cell Biochem 2013,
114:192203.
2. Hjorth E, Zhu M, Toro VC, Vedin I, Palmblad J, Cederholm T, Freund-Levi Y,
Faxen-Irving G, Wahlund LO, Basun H, Eriksdotter M, Schultzberg M:
Omega-3 fatty acids enhance phagocytosis of Alzheimers diseaserelated amyloid-42 by human microglia and decrease inflammatory
markers. J Alzheimers Dis 2013, 35:697713.
3. Miles EA, Calder PC: Influence of marine n-3 polyunsaturated fatty acids
on immune function and a systematic review of their effects on clinical
outcomes in rheumatoid arthritis. Br J Nutr 2012, 107(Suppl 2):S171S184.
4. Singer P, Shapiro H, Theilla M, Anbar R, Singer J, Cohen J: Antiinflammatory properties of omega-3 fatty acids in critical illness: novel
mechanisms and an integrative perspective. Intensive Care Med 2008,
34:15801592.
5. Oz HS, Chen TS, Neuman M: Nutrition intervention: a strategy against systemic
inflammatory syndrome. JPEN J Parenter Enteral Nutr 2009, 33:380389.
6. Yu M, Gao Q, Wang Y, Zhang W, Li L, Wang Y, Dai Y: Unbalanced omega-6/
omega-3 ratio in red meat products in China. J Biomed Res 2013, 27:366.
7. Wu Z, Qin J, Pu L: Omega-3 fatty acid improves the clinical outcome of
hepatectomized patients with hepatitis B virus (HBV)-associated
hepatocellular carcinoma. J Biomed Res 2012, 26:395399.
8. de Miranda Torrinhas RS, Santana R, Garcia T, Cury-Boaventura MF, Sales
MM, Curi R, Waitzberg DL: Parenteral fish oil as a pharmacological agent
to modulate post-operative immune response: a randomized, doubleblind, and controlled clinical trial in patients with gastrointestinal cancer.
Clin Nutr 2013, 32:503510.
9. Pradelli L, Mayer K, Muscaritoli M, Heller AR: n-3 fatty acid-enriched parenteral nutrition regimens in elective surgical and ICU patients: a metaanalysis. Crit Care 2012, 16:R184 [Epub ahead of print].
10. Cozzaglio L, Balzola F, Cosentino F, DeCicco M, Fellagara P, Gaggiotti G,
Gallitelli L, Giacosa A, Orban A, Fadda M, Gavazzi C, Pirovano F, Bozzetti F:
Outcome of cancer patients receiving home parenteral nutrition.
J Parenter Enteral Nutr 1997, 21:339.
11. Nordenstrom J, Thorme A: Benefits and complications of parenteral
nutritional support. Eur J Clin Nutr 2000, 48:53.
12. Heller AR, Rssler S, Litz RJ, Stehr SN, Heller SC, Koch R, Koch T: Omega-3
fatty acids improve the diagnosis-related clinical outcome. J Crit Care
Med 2006, 34:972.
13. Mayer K, Schaefer MB, Seeger W: Fish oil in the critically ill: from
experimental to clinical data. Curr Opin Clin Nutr Metab Care 2006, 9:140148.
14. Li Q-r, Tan L, Wang C, Ma J, Guowang X, Li J: Polyunsaturated fatty acids
(20: 5 n3) changes of lipid composition in Jurkat T cell membrane
subdomains. Acta Nutrimenta Sinica 2006, 28:124127.
15. Wang Z, Li Q, Hao Q, Li Y, Li N, Li J: Effect of -3 polyunsaturated fatty
acids on phenotypes and functions of dendritic cells. Chinese J Exp Surg
2005, 22:14271429.
16. Pscheidl E, Schywalsky M, Tschaikowsky K, Bke-Prls T: Fish oil -supplemented
parenteral diets normalize splanchnic blood flow and improve killing of
translocated bacteria in a low dose endotoxin rat mode. J Crit Care Med
2000, 28:14891496.
17. Koch T, Heller AR: Benefits of -3 fatty acids in parenteral nutrition. J Clin
Nutr S 2005, 1:1724.
doi:10.1186/1475-2891-13-25
Cite this article as: Wei et al.: A prospective, randomized, controlled study
of -3 fish oil fat emulsion-based parenteral nutrition for patients following
surgical resection of gastric tumors. Nutrition Journal 2014 13:25.